- In March 2024, the Government of India announced the expansion of its National Cancer Grid (NCG) initiative by integrating 40 new regional cancer centers across the country, many of which are equipped with advanced radiotherapy facilities. This strategic move aims to standardize cancer treatment and enhance access to modern radiotherapy in underserved areas. The initiative underscores India's commitment to building a robust oncology infrastructure capable of addressing the country's growing cancer burden
- In February 2024, Bangladesh's Ministry of Health, in partnership with the International Atomic Energy Agency (IAEA), commissioned new linear accelerators in two government hospitals under its Cancer Control Plan. This development marks a significant step in improving nationwide access to external beam radiotherapy and highlights Bangladesh’s ongoing efforts to expand and modernize its oncology services through international collaborations
- In January 2024, Sri Lanka’s National Cancer Institute launched its digital radiotherapy planning system with support from global health partners. The system enables more accurate and efficient treatment planning using cloud-based technologies and AI-assisted tools. This advancement reflects Sri Lanka’s focus on elevating treatment precision and adopting modern cancer care protocols in public institutions
- In December 2023, Nepal’s Bhaktapur Cancer Hospital became the first in the country to adopt 3D conformal radiotherapy (3D-CRT) supported by international training programs and donations of treatment planning equipment. This milestone highlights Nepal’s progress toward integrating modern radiotherapy technologies and building local capacity through skilled workforce development and infrastructure enhancement
- In November 2023, Tata Memorial Centre in India entered a research collaboration with leading global medical device manufacturers to pilot AI-based adaptive radiotherapy solutions. The project is designed to improve treatment accuracy and personalize radiotherapy regimens. This collaboration emphasizes India’s growing role in global oncology innovation and reflects the increasing focus on precision medicine in the region’s radiotherapy landscape
